Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)
Clinical trial NCT02251990 · COMPLETED
Trial details
- NCT number
- NCT02251990
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-28
- Primary completion
- 2016-09-27
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.